Our study revealed that the underlying mechanisms of anti-AD effects of CF are likely to involve inhibition of the inflammatory response, response to lipopolysaccharides, protein phosphorylation, negative regulation of apoptotic processes, and positive regulation of the ERK1 and ERK2 cascades. The gene discussed is MAPK3; the disease is cystic fibrosis.